Stay updated on nickel market trends, EU's Critical Raw Materials Act projects, Indonesian royalties, and global company ...

Codix Pharma's journey in the Nigerian pharmaceutical industry is one of innovation, strategic leadership, and a bold commitment to leading the way in health-tech solutions. Since it commenced ...

Tech stocks, like Microsoft, demonstrate strong growth due to AI integration, raising investor interest. Nvidia's gains in AI-driven data center revenue signal robust sector opportunities.

Shares of midcap companies extended their rally on March 21 to push the Nifty Midcap index up by over a percent around 51,751, extending gains for a fifth session and rising nearly 8 percent this ...

American pharmaceutical major Eli Lilly and Company on Thursday (March 20, 2025) launched its diabetes and obesity management drug Mounjaro (tirzepatide) in India. The company launched the drug in ...

Morning Hubsters. John R Fischer here with the US Wire from the New York newsroom. Pharmaceutical companies are spending more on marketing than ever before, driven by factors including the aging ...

Management reaffirmed the fiscal 2025 midpoint guidance for organic ASV growth at 5%, with a narrowed growth range reflecting 4.4% to 5.8%. Revenue guidance was adjusted to $2.305 billion to $2. ...

A new report released by Ernst & Young LLP and Innovation Works, reveals that Pittsburgh’s technology ecosystem saw a record number of venture capital (VC) deals in 2024, with AI and life sciences ...

Our experts review more than 1,500 technology products each year. Our mega-guide, updated monthly, scopes out the very best cost-conscious products across 15 key categories.

Some of the biggest names in health tech and pharma have been selected to take part in a new FDA fast-track to accelerate digital health approvals. Announced by FDA Commissioner Scott Gottlieb in ...

Elon Musk reported a significant cyberattack on X, potentially by a coordinated group or nation. Nikesh Arora, CEO of Palo Alto Networks, has offered assistance. Pro-Palestinian group Dark Storm ...

Sun Pharmaceutical Industries has agreed to acquire US-based cancer drug maker in a deal valued at $355 million in upfront cash payment, India’s biggest pharma company said in a press release ...